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We investigate the possibility that alterations in the calcium movements of the hypertrophicd rat heart might involve sarcoplasmic reticulum (§R) 
ryanodine receptors. A decreased receptor density was observed with severe hypertrophy (0.26+0.05 and 0.35+0.06 pmol/mg protein and 170 
and 366 receptors/flm* of SR in 50--80% hypertrophy and control, respectively); however, the total number of receptors per left ventricle was 
unchanged. The dissociatic:: constant (0.7 nM) was similar in both hypertrophied and control left ventricles. Thus the decreased ensity of the 
ryanodine receptors may participate in altered calcium movements in hypertrophied rat heart. 
Raynodine receptors; Hypertrophied rat heart 
1 t INTRODUCTION 
In cardiac muscle, the key events in excitation- 
contraction (E-C) coupling comprise the calcium influx 
by the L-type calcium channel and the subsequent 
calcium release from the terminal cisternae of the sar- 
coplasmic reticulum (§a) [I]. Cardiac hypertrophy in- 
duced by pressure overload is an adaptational mechan- 
ism which is associated with a prolongation of the as- 
tion potential duration [a], a delayed calcium transient 
[3] and a depressed contractility [$I. These modifica- 
tions suggest that functional changes in E-C coupling 
might occur in the hypertrophied heart. Recent studies 
on the dihydropyridine (DHP) receptors [5] and cal- 
cium channels [6] during the compensated phase of 
hypertrophy demonstrated that a direst change in the 
calcium influx across the sarcolemma is not responsible 
for these functional alterations. Moreover, the calcium 
sensitivity of the myofibrils was unchanged [7] and thus 
cannot account for the depressed contractility of hyper- 
trophied cardiac muscle. In contrast, the isomyosin 
shift from Vl to V3 might participate in the depressed 
contractility of hypertrophied rat heart [8] but not in 
other species where adult hearts contain almost ex- 
clusively V3 isomyosin. Another important alteration 
was recently reported in hypertrophied rat hearts 
demonstrating that both the density and activity of the 
SR Ca2+ ATPase decreased which probably contribute 
to the delayed relaxation [9]. 
We suggest that the calcium release from the SR 
which is directly involved in the increased intracellular 
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concentration of ionized calcium [l] might also play a 
major role in the functional changes of the hyper- 
trophied heart. In cardiac muscle, this release occurs 
through a channel which is generally referred to as the 
ryanodine receptor [lo]. To test this hypothesis, we 
measured the density and affinity of the ryanodine 
receptors on crude sarcolemmal membrane prepara- 
tions from rat left ventricles (LV) hypertrophied by 
pressure overload. 
In this work, we reported the first observations that 
the density of ryanodine receptors is decreased by 
pressure overload without changes in the binding affini- 
ty. These results suggest that modifications in the SR 
calcium release could account, at least in part, for the 
alterations in E-C coupling seen with hypertrophy. 
2. MATERIALS AND METHODS 
2. I. Aortic stenosis 
Male Wistar rats with body weights ranging from 180 to 220 g were 
anesthetized by intraperitoneal injection of 0.05 mg/g sodium pen- 
tobarbital. Cardiac hypertrophy was induced by an abdominal aortic 
constriction [S]. Compensated hypertrophy was stable after 2 weeks 
and was maintained for 2 months. The magnitude of hypertrophy was 
estimated one month after surgery by comparison of the LV 
weight/body weight ratio (LVW/SW) of operated animals with that 
of sham-operated animals. Only animals with a ratio ~2.5 were 
selected for use in the binding studies. The sham-operated animals 
(LVW/BW = 2.07 ~0.1 I) underwent an identical procedure except 
that the hemoclip was not placed around the aorta. We checked that 
anatomical data of control and sham-operated animals of the same 
weight were not modified. 
2.2. Heart rnernbrane preparation 
Hearts were quickly removed and immediately perfused with 5 ml 
of 0.15 M NaCl. The LV (including the septum) was excised and 
weighed. LV and septum (0.6-1.2 g) were minced into small pieces in 
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the presence of buffer A (200 mM sucrose, 20 mM Tris-HCI. 0.4 mM 
CaClz, pH 7.0, with 1.1 FM leupeptin, 0.7 FM pepstatin, 0.7 pM 
aprotinin, 120 PM phenylmethane-sulfonyl fluoride, 1 mM iodoacet- 
amide) and homogenized in 7 ml of buffer A/g wet weight tissue, us- 
ing a Polytron PT20 (two bursts of 5 s at half maximal speed). The 
homogenate was filtered, diluted to IS ml and centrifuged at 41 000 
x g for 50 min in a Sorvall SS34 rotor. The resulting pellet was 
homogenized in ice cold buffer A. Aliquots of crude sarcolemmal 
fraction (6-8 mg protein/ml) were stored in liquid nitrogen. Protein 
content was determined by the method of Lowry et al. [I I], using 
bovine serum albumin as a standard. 
2.3. Binding srudies 
Characteristics of the ryanodine receptors were assessed by 
[‘H]ryanodine(60-95 Ci/mmol: New England Nuclear) binding using 
I2 concentrations (0.08-10 nM) of the ligand. Crude sarcolemmal 
fractions were diluted fo 100 gg protein/ml and incubated at 37°C in 
a buffered medium containing 1 M KCI. 10 pM free-calcium, 50 mM 
PIPES-KOH (pH 7.4) 11.21 and proteolytic enzyme inhibitors. Unless 
otherwise specified, incubation times were I20 min. The medium was 
then automatically filtered through a Whatman GF-B filter in a 
Skatron apparatus. Filters were washed with 3 x 5 ml cold water. 
Non-specific binding was determined by addition of 5 PM ryanodine 
(Calbiochem) to the incubation medium. Radioactivity was counted 
after addition of 5 ml of scintillation fluid (Hionic fluor; Packard) in 
an LKB scintillation counter. We ensured that the specific binding 
was proportional to the protein concentration and that ligand concen- 
trations always exceeded the receptor coI.:centration. All incubations 
were performed in triplicate and the number of experiments were at 
least 3 per animal. 
2.4. Slaristical analysis 
Estimates of equilibrium binding parameters (dissociation constant 
(Kd) and maximal density (B,,&) were obtained from Scatchard plot 
analysis performed with the ‘Ligand’ program. Results are presented 
as mean + SD. The statistical differences between mean values fol 
the 2 groups were evaluated by Student’s l-test. A value of PcO.05 
was considered a significant difference between the 2 groups. 
3. RESULTS 
3.1. Anatomical data 
Anatomical data of the sham-operated (designated as 
control) and experimental rats were shown in Table I. A 
significant increase in LV mass relative to body weight 
was obtained in 20% of the operated rats. Two groups 
of animals were selected: the first group had average 
hypertrophy of 3Ok 5% and the second one of 
65 + 15%. Whatever the indices (LVW or LVW/BW 
ratio) the degree of hypertrophy for the 2 experimental 
groups was statistically different from that of the con- 
trol group. 
3 2. f HJRyanodine binding 
In order to avoid a possible loss of membrane recep- 
tors during purification procedures, LV homogenates 
were centrifuged and the crude pellets used in the 
binding experiments. E31-I]Ryanodine bound in a rever- 
sible and saturable manner to this crude fraction and 
the time course of ryanodine binding at 1 nM was 
similar in preparations from control and hypertrophied 
LV (data not shown). Equilibrium was reached after 90 
min and was stable for at least 3 h. The recovery of pro- 
teins and ryanodine receptors in the homogenates and 
the crude fractions from control and hypertrophied rat 
LV are shown in Table II; a total recovery of the 
ryanodine receptors was obtained in the crude fractions 
of the 2 groups. 
The Scatchard analysis of specific [3H]ryanodine 
binding revealed a single class of high affinity sites in 
both control and hypertrophied LV preparations (Fig. 
Table I 
Condition n 
General characteristics of sham-operated and operated rats 
- 
Body Wt LV wt LVWt/BWt 
Control 
(9) W-a: (w/g) 
7 335 f 32 680 r 60 2.07-cO.lI 
Hypertrophy 
25-35% 6 340*331 890~ SO*** 2.62 + O.OS*“* 
50-80% 9 320 + 29.5 1070+105*** 3.33 + 0.24*** 
Values are means_cSD. The Student’s f-test was done between control and hypertrophied group. ***P>O.OOl 
Table II 
Characteristics of the homogenates and pellets from control and hypertrophied rat left ventricles 
Condition rt Homogenate Pcllct 
(mg protein/g LV) (mg protein/g LV) Protein yield (070) Ryanodine receptor yield (S) 
Control 7 166 -I- 39 89.6~22 53.8k6.7 97r I3 
Hypertrophy 
25-35% 6 I62 r? 43 91.51-21 56.5” 18.5 88t I7 
50-80% 9 lS3 c45 91.8+28 57.6k3.08 103~~18 
Ryanodine receptor yield has been calculated for each group from 4 experiments of specific binding at 4 nM ryanodine with 200 and 100 lg pro- 
tein/ml for homogenates and pellets, respectively. 
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Fig. 1. Scatchard plot analysis of specific [“Hlryanodine binding to 
crude fractions of LV from control ( q ) and SO-80% hypertrophied 
( q ) rat hearts. Values represent mean of 3 experiments per crude frac- 
tion from 7 control and 9 hypertrophied animals. B= bound 
ryanodine; B/F= bound ryanodinejfree ryanodine. 
I). The non-specific binding of [3H]ryanodine to crude 
fractions from control and hypertrophied LV was less 
than 20% at 10 nM ryanodine. The dissociation con- 
stant values were comparable for control and hyper- 
trophied LV preparations (0.71 -I- 0.36 and 0.62 f 0.26 
r&l, respectively) (Table III). In contrast, the maximal 
number of [‘Hlryanodine binding sites tended to 
decrease in preparation of mildly hypertrophied LV and 
was significantly decreased in those from severely 
hypertrophied LV when compared with control LV 
(Table III). Due to the similar yields of protein and the 
total recovery of the ryanodine receptors in hyper- 
trophied and control LV expression of the number of 
receptors per g of LV or per LV and comparison be- 
tween hypertrophied and control LV were valid. The 
values in Table II demonstrate that the number of 
[3H]ryanodine binding sites per LV remains similar in 
the 3 groups whereas the number of receptors per g of 
LV was significantly reduced with severe hypertrophy 
when compared to controls. 
4. DISCUSSION 
Alterations in E-C coupling and in calcium handling 
have been often reported for hypertrophicd hearts 
[2,3]; however, it is not well established which of the 
functions involved in E-C coupling participate in those 
alterations. In this work, we observed a decrease in the 
density of the ryanodine receptors in severely hyper- 
trophied rat LV. This result suggests that a decrease 
either in the amount or velocity of SR calcium release 
might occur which could account for the delayed 
calcium transient and/or the depressed contractility 
reported in the hypertrophied heart [3,4]. 
We estimate the number of ryanodine receptors of 
normal rat hearts per g of LV based upon the total 
receptor recovery in the preparation. Our results show 
that this number (26 pmol/g LV) was higher in the rat 
than in dog (20 pmol/g LV) [l] or rabbit (16 pmol/g 
LV, assuming that the protein yield of crude 
homogenate per g of LV is similar in the rat and the rab- 
bit heart) [ 131. If these receptors maintain similar pro- 
perties among species, our data are consistent with the 
higher participation of the §R in the increase of in- 
tracellular free calcium in the rat relative to other 
species [14,15]. 
In moderate hypertrophy, no difference could be 
demonstrated between control and hypertrophied LV 
for the &, the association rate or the number of 
ryanodine receptors per mg of protein and per LV even 
though the LVW and LVW/BW ratio were significantly 
increased. These data are consistent with the previous 
observations showing unchanged Ca2 + -ATPase ml?NA 
and protein accumulations in the SR of mildly hyper- 
trophied rat LV [9]. 
In severe hypertrophy, the & and the association rate 
of the ryanodine for its receptor were unchanged and 
this finding might suggest that the same ryanodine 
receptor is expressed during hypertrophy. By contrast, 
the density of the ryanodine receptors was decreased by 
26% (0.26?~0.05 and 0.35 +0.06 piilol/mg protein in 
hypertrophied and control LV preparations, respective- 
ly) but the total number per LV remains constant 
(23.9 + 7.8 and 22.4 & 6.2 pmol/LV in hypertrophied 
and control LV, respectively). To express and compare 
the density of the receptors in the control and hyper- 
trophied myocyte, one might take into account the 
structural changes described by Anversa [6]. First, as 
hypertrophy occurs without cell division, the number of 
ryanodine receptors per hypertrophied myocyte re- 
mains constant. This number, according to the number 
of myocytes per LV (44 x 10”) is 31.3 and 29.3 x lo4 
Table 111 
Characteristics of the ryanodine receptors in crude microsomal fractions from control and hypertrophied rat left ventricles 
Condition II Kd FL,,, &,;I% B ,na* 
0-M (pmol/mg protein) (pmol/g LV) (pmol/LV) - 
Control 7 0.71 k 0.36 0.35 + 0.06 31.3k7.2 22.4 + 6.2 
Hypertrophy 
25-35% 
50-80% 
6 0.62 f 0.26 0.3 1 I- 0.04 26.6-c 3.f; 22.5 k 1.8 
9 0.47 co.21 0.26 z!z O.OS’** 24.0~ 5.5* 23.9zk7.8 
Experiments were performed 3 times on each fraction. Values are means k SD. ‘P~0.05, ***P<O.Ol 
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receptors per hypertrophied and control myocyte, 
respectively. Second, according to (i) the localization of 
the ryanodine receptors in the junctional SR [17], (ii) 
the surface of the junctional SR in control rat myocyte 
which represented I/IO of the total SR area 1181 and (iii) 
the high increase in volume and surface of the SR (ap- 
proximately two-fold for a 60% hypertrophy) [16] in 
the hypertrophied rat myocyte, the density of the 
ryanodine receptors can be estimated to 170 and 
366/pm2 in the hypertrophied and the control myocyte, 
respectively. This density is thus decreased by about 
55% in the hypertrophied myocyte. 
in the heart, resent studies on the SR calcium- 
induced release of calcium [ 191 have underlined the trig- 
ger role of the slow Ca2+ current in this mechanism. 
Therefore, we considered the ratio of the ryanodine and 
DHP receptors in the hypertrophied myocyte. We have 
previously shown that the number of DHP receptors [5] 
and the amplitude of the Ca2+ current [6] per hyper- 
trophied myocyte is increased in such a way that the 
density of the receptors and of the current remains con- 
stant. The total number of DHP receptors calculated 
according to the morphological studies of Anversa [16] 
was estimated at 12 x lo4 and 20 x lo4 per control and 
hypertrophied myocyte, respectively; the mean receptor 
density on the total sarcolemma at lS/pm’ in control 
and hypertrophied myocytes [20]. The ratio of the 
ryanodine receptor density to the DHP receptor density 
decreases from 24.4 in the control myocyte to 11.3 in 
the hypertrophied myocyte. Although the density of 
receptors is not indicative of channel activity, these data 
strongly suggest hat the calcium release channel of the 
SR is a limiting parameter in the increase in intracellular 
free calcium during E-C coupling of the hypertrophied 
rat heart. It might also be emphasized that the 
ryanodine receptor density is decreased by the same 
order of magnitude as the density of another main SR 
protein, the Ca “’ -ATPase [12] which is responsible for 
the uptake of calcium during the relaxation. A decrease 
in these two functions could be the first sign of poor 
regulation of calcium movements and homeostasis in 
the compensated phase of hypertrophy. 
Acknowledgements: This study was supported by the ‘FCdCration 
Francaise de Cardiologie’. C. Sainte Beuve was supported by a 
‘Federation Francaise de Cardiologie’ fellowship. 
REFERENCES 
ill 
121 
131 
141 
PI 
PI 
[71 
181 
191 
[lOI 
[Ill 
iI21 
I131 
ttz; 
[I61 
[I71 
[I81 
1191 
PO1 
Feher. J.J. and Fabiato, A. (1990) in: Langer G.A., ed. Calcium 
and the Heart. Raven Press NY, 199-268. 
Ten Eick, R.E. and Basset, A.L. (1983) in: Function of the Heart 
in Normal and Pathological States (Sperelakis, N. ed.) pp. 
245-67, Nijhoff, The Hague. 
Gwathmey, J.K. and Morgan, J.P. (1985) Circ. Res. 57, 
836-843. 
Lecarpentier. Y., Bugaisky, L.B., Chemla, D., Mercadier, J.J., 
Schwartz, K.. Whalen, R.G. and Martin, J.L. (1987) Am. J. 
Physiol. 252, H275-282. 
Mayoux. E., Callens, F., Swynghedauw, B. and Charlemagne, 
D. (1988) J. Cardiovasc. Pharmacol. 12, 390-396. 
Scamps, F., Mayoux, E., Charlemagne, D. and Vassort, G. 
Circ. Res. 67, 199-208. 
Ventura-Clapier, R., Mekhfi, H., Oliviero, P. and Swynghe- 
dauw, B. (1988) Am. J. Physiol. 254, H517-H524. 
Lompre. A.M., Schwartz, K., d’Albis, A., Lacombe, G., 
Thiem, N.V. and Swynghcdauw, B. (1979) Nature 282. 105-107. 
De la Bastie, D., Levitsky, D., Rappaport, L.. Mercadier, J.J., 
Marotte. F., Wisnewsky, C., Brovkovich. V., Schwartz, K. and 
Lompre, A.M. (1990) Circ. Res. 66, 554-X4. 
Rardon, D.P., Cefali. D.C., Mitchell, R.D., Seiler, SM. and 
Jones, L.R. (1989) Circ. Res. 64, 779-789. 
Lowry, O.H., Rosenbrough. N.J., Farr, A. and Randall, R.J. 
(1951) J. Biol. Chem. 193. 2G5-275. 
Imagawa, T., Takasago, T. and Shigekawa, M. (1989) J. 
Biochem. 106, 342-348. 
Lai, F.A. and Meissner, G. (1989) J. Bioenerg. Biomem. 21, 
227-246. 
Fabiato, A. (1982) Federation Proc. 41, 2238-2244. 
Bers, D.M. (1985) Am. J. Physiol. 248, H366-381. 
Anversa. P., Olivetti, G., Melissari, M. and Loud, A.V. (1979) 
Lab. Invest. 40, 341-349. 
Block, B.A., lmagawa, T., Campbell, K.P. and Franzyni- 
Armstong, C. (1988) J. Cell. Biol. 107, 2587-2600. 
Page, E., Earley, J. and Power B. (1973) Am. .I. Cardiol. 31, 
172-181. 
Beuckelmann, D.J. and Wier. W.G. (1988) J. Physiol. 405, 
233-255. 
Mayoux, E. and Swynghedauw, B. (1990) Swynghedauw B. ed., 
pp. 225-232, INSERM/John Libbey Eurotext. 
138 
